Summary
Signal counts
Assets tracked: 1
Watchlist assets: 1
Registry stop assets: 0
Sponsor overview
Women's Hospital School Of Medicine Zhejiang University
Public clinical-program risk signals across linked oncology Phase 2 assets for this sponsor.
Evidence links
Public sources
https://clinicaltrials.gov/study/NCT05824494 | https://clinicaltrials.gov/study/NCT07243951
Assets
Linked programs
- Cadonilimab: Watchlist Signal (3/5)